Galaxy SEAL IT Trial: Enrollment Complete & Pivotal Results Ahead
A significant step forward in the treatment of brain aneurysms has been taken as Galaxy Therapeutics announced the successful completion of enrollment in its pivotal SEAL IT trial. This isn’t simply about a trial finishing; it signals a potential broadening of treatment options for a condition affecting millions and a move towards more effective, less … Read more